To connect the expertise and experience of former (corporate retired) senior executives and researchers with new generation leadership, to use judgement and technology to meet strategic and operational business challenges.
The practical knowledge, experience and business connections of former senior executives are valuable, overlooked resources, and often not accessible.
New Guide intends to facilitate the flow of know-how from former senior executives to benefit start-up and emerging companies. These considerations motivated launching New Guide in July 2021.
New Guide is an information platform that comprises a website to profile advisors.
A Management Committee supervises the website, assigns clients to advisors, reviews and selects advisor applicants, and sets fee guidelines. Volunteer advisors staff the Management Committee.
Currently, all members of the Management Committee are based in Germany.
There are no financial transactions between the platform and client, or between the platform and advisor. Client engagements are customized consulting contracts negotiated between an independent advisor and a client. There are no contracts with New Guide. The platform provides information and facilitates connections at no charge.
For additional information about the platform, please send an email to [email protected].
Members of the Management Committee
Egon P. Amann, Ph. D, Professor Emeritus, has 32 years of experience in the pharmaceutical & diagnostics industry in R&D, strategic planning, business development and quality management. He held senior management positions for Hoechst/Behring, Hoechst Japan Limited, Dade Behring and Siemens Healthcare Diagnostics.
Hans A. Küpper, Ph. D. has over 40 years of experience in biotechnology and life sciences ranging from R&D and management to venture funding. He held management positions at Biotech (Biogen) and big Pharma (Behring/Hoechst), was for 20 years partner of a VC firm and on the Board of 15 early stage companies.
Ekkehard Leberer, Ph.D., Professor of Biochemistry, has 35 years of experience in pharmaceutical industry and life sciences. He held senior management positions in R&D for Hoechst Marion Roussel, Aventis and Sanofi.
Geoffrey Samuels, a former business writer whose clients have included Deloitte, Insead, and Roland Berger Strategy Consultants, is a graduate of Stanford University and the Harvard Kennedy School.